Skip to main content
Fuan Pharmaceutical （Group）co.,Ltd logo

Fuan Pharmaceutical （Group）co.,Ltd — Investor Relations & Filings

Ticker · 300194 ISIN · CNE1000011G4 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,014 across all filing types
Latest filing 2020-03-19 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300194

About Fuan Pharmaceutical （Group）co.,Ltd

https://www.fapharm.com

Fuan Pharmaceutical (Group) Co., Ltd. is an integrated pharmaceutical enterprise specializing in the research, development, production, and distribution of a wide range of chemical drugs. The company operates across the entire value chain, encompassing pharmaceutical intermediates, active pharmaceutical ingredients (APIs), and finished dosage forms. Its product portfolio primarily focuses on anti-infectives, particularly cephalosporins and penicillins, as well as treatments for cardiovascular diseases, oncology, and respiratory conditions. Fuan Pharmaceutical maintains large-scale manufacturing facilities and emphasizes technological innovation to support its diverse pipeline of generic and specialized medications. The group serves both domestic and international markets, providing essential healthcare solutions through its network of subsidiaries and specialized production bases.

Recent filings

Filing Released Lang Actions
关于公司投资设立的基金完成备案的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by 福安药业 (Fuan Pharmaceutical) regarding the completion of the filing (备案) of a fund investment established by the company. It details the fund's registration with the China Securities Investment Fund Association, including the filing code, fund name, manager, and filing date. The document is short (800 characters) and serves as an official notice of the fund's regulatory filing status rather than a detailed financial report or analysis. It does not contain financial statements, management discussion, or detailed financial data. Therefore, it is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2020-03-19 Chinese
关于员工持股计划减持计划实施期间届满暨实施情况公告
Transaction in Own Shares Classification · 95% confidence The document is an announcement regarding the expiration and implementation status of an employee stock ownership plan's share reduction plan. It details that no shares were actually reduced during the plan period and confirms compliance with relevant securities laws and regulations. The document is short (1019 characters) and serves as a formal disclosure of shareholding changes related to insiders or employees, specifically about share reduction plans. It does not contain financial statements or detailed financial data, nor is it a report or presentation. It fits the category of Transaction in Own Shares (POS), which covers company announcements about share repurchases or sales by insiders or employee plans.
2020-03-12 Chinese
对外投资项目进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by 福安药业 (Fuan Pharmaceutical Group) regarding the progress of an external investment project. It details the company's board meetings approving the acquisition of a 51% stake in Red Realty LLC, the establishment of a subsidiary in the US to facilitate this acquisition, and the payment progress of the transaction consideration. The document is relatively short (1066 characters) and focuses on the status update of a capital investment transaction rather than providing comprehensive financial data or detailed financial statements. It does not contain financial results, audit opinions, or management discussions typical of annual or interim reports. It also does not announce voting results, changes in management, or legal proceedings. The content aligns with updates on company fundraising or capital structure changes, specifically the acquisition and investment progress. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2020-03-06 Chinese
2019年度业绩快报
Earnings Release Classification · 95% confidence The document is titled '2019 年度业绩快报' which translates to '2019 Annual Performance Express Report' or '2019 Annual Earnings Quick Report'. It contains preliminary financial data for the year 2019, including revenue, profit, net income, and other financial metrics. The document explicitly states that the data is preliminary and unaudited, and that the final audited data will be disclosed in the annual report. This indicates it is a quick earnings release rather than a full annual report. The document length is 2117 characters, which is relatively short and consistent with an earnings release rather than a full annual report. The document also includes a disclaimer about the preliminary nature of the data and risk warnings to investors, typical of earnings releases. Therefore, this document fits the definition of an Earnings Release (ER) as it is an initial announcement of yearly financial results with key highlights only, not the full detailed annual report (10-K). FY 2019
2020-02-27 Chinese
关于股东股份减持计划实施期间届满暨实施情况的公告
Major Shareholding Notification Classification · 100% confidence The document is an announcement regarding the completion of a shareholder share reduction plan by major shareholders of the company. It details the number of shares reduced, the methods of reduction, dates, and the shareholding changes before and after the reduction. It references regulatory requirements for disclosure of such shareholding changes and confirms compliance. There is no financial report, earnings data, or management discussion. The document is a formal disclosure of a significant shareholding change by major shareholders, fitting the category of Major Shareholding Notification.
2020-02-03 Chinese
关于控股股东部分股份解除质押的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the release of a pledge on shares held by a controlling shareholder. It details the number of shares released from pledge, dates, and related parties. There is no financial report, earnings data, or management discussion. The content fits the category of a capital structure update related to share pledges. This corresponds to Capital/Financing Update (CAP). The document length is short and it is not a report publication announcement or certification. Therefore, the classification is CAP with high confidence.
2020-02-03 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.